FindTrial
Sign In

study of injection pain induced by remazolam tosylate

Comparison of the effects of different strategies on alleviating injection pain induced by remazolam tosylate

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059233
Enrollment
Unknown
Registered
2022-04-27
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

injection pain

Interventions

C:normal saline
L:lidocaine
R:Remifentanil

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients who plan to undergo painless gastroscopy; 2. ASA grading is 1-2; 3. The age is 18-60 years old.

Exclusion criteria

Exclusion criteria: 1. Liver and kidney insufficiency; 2. Complicated with diabetes or hypertension; 3. Abnormal body sensation or motor function; 4. Acute and chronic pain; 5. Mental illness; 6. Have a history of allergy to the drug in the test.

Design outcomes

Primary

MeasureTime frame
pain;—

Secondary

MeasureTime frame
Blood pressure / heart rate / oxygen saturation;MOAA/S;—

Countries

China

Contacts

Public ContactSong Zhiping

The First Affiliated Hospital of Nanchang University

pig.12345@163.com+86 15979079071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026